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Conclusions: Long-course chemo-radiotherapy with 
simultaneous integrated boost is safe in the treatment of 
rectal cancer patients. Patients presenting more pronounced 
and/or several toxicity showed a significant trend toward a 
better TRG. Immunological local reactions could potentially 
explain these results, and should be further explored. 
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Purpose/Objective: UK IMRT anal cancer treatment uses 
large fields to uninvolved nodal groups (40Gy) with 
simultaneous integrated boost to the primary tumour (50.4Gy 
T1/T2; 53.2Gy T3/T4) and involved nodes (50.4Gy). With a 
simple bony match online, iliac nodes are well covered and 
the margins required are well documented, however the 
margins for prophylactic inguinal nodes (pIN) and primary 
tumour are not well established as data from daily imaging 
are limited; these form the focus of this study. 
Materials and Methods: Anal cancer patients treated at a 
single institution under current UK IMRT guidelines were 
screened; 11 consecutive inguinal node negative patients 
were studied. Supine treatment comprised 28 fractions with 
daily imaging: CBCT fractions 1-5, 10, 15, 20 and 25; 
orthogonal kV imaging all other fractions. 
99 CBCT’s were re-matched automatically to the planning 
CT. A bony match was performed using a clipbox 
encompassing the bony pelvis. Re-matches were performed 
within the same clipbox using the clinician defined tumour 
(GTVA) as a region of interest (ROI), then repeated with the 
pIN ROI. Accuracy of auto-matches were assessed visually to 
ensure clinical relevance. 
Bony match values were subtracted from the GTVA and pIN 
measurements to evaluate differences in the optimal 
treatment position for the tumour or the nodes relative to a 
simple bony match. Margins were calculated using van Herk’s 
recipe.  
Results: Differences (mm) between GTVA/ bony matches 
were larger than inguinal/ bony matches in all axes ( lat -3.1 
to 4.2; -2 to 1.5, vert- 6.9 to 12.7; -3.6 to 2.9, long -13.3 to 
17.2; -8.5 to 7.3 in GTV and pIN respectively). This was 
statistically significant in the long axis (p<0.05) shown in 
Fig.1. GTVA had consistently larger systematic and random 
errors than pIN, reflected in the margin calculations (mm): 
GTVA lat 2.8, long 9.8, vert 5.8; pIN lat 1.5, long 3.1, vert 
3.1. 
Conclusions: With a simple bony match, the margin around 
pIN can be reduced to 1.5mm laterally and 3.1mm in all 
other directions potentially reducing toxicity to the groin, 
genitalia and bladder. 
The GTVA to PTV margin incorporates microscopic disease, 
the motion of the soft tissues of the anus which can be 
affected by tumour size, location, bowel filling and BMI; and 
the set up error. The margin reported in this study covers set 
up error and soft tissue motion of the anus. An individualised 
margin incorporating these factors can be calculated and 
applied during the treatment course with the aim of reducing 
toxicity in adjacent organs such as vagina, bladder and penile 
bulb.  
Further investigation is warranted to demonstrate reduced 
toxicities with these strategies. 
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Purpose/Objective: Multidisciplinary clinics (MDCs) offer 
patients an initial evaluation by all three oncologic 
specialists, radiologists, pathologists, and others. The costs 
and overall value (defined as quality divided by costs) of care 
in MDCs are not well-described. For patients with pancreatic 
cancer, we compared direct care costs, patient retention 
rates, patient phone calls with symptoms, patient ED visits 
with symptoms, and survival outcomes for patients treated in 
a pancreatic MDC to patients evaluated outside of the MDC. 
Materials and Methods: Two cohorts of patients with 
pancreatic cancer seen at our institution were analyzed and 
